Pearl Therapeutics is developing unique dual and triple combination products for the treatment of widely prevalent respiratory diseases, including chronic obstructive pulmonary disease. Pearl's current focus is on making advanced inhaled therapies available to broad patient populations via familiar and accepted metered dose inhalers.

Latest News

May 14, 2012

Pearl Therapeutics Phase 2b Twice-Daily...

April 3, 2012

Pearl Therapeutics Creates Nanogram-Dose...

January 6, 2012

Pearl Therapeutics Announces Successful...

More Press Releases